Cytokinetics Profit Margin Trend from 2010 to 2022
CYTK  Stock  USD 49.47 3.27 6.20% 
Cytokinetics  Profit Margin 
Check Cytokinetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cytokinetics main balance sheet or income statement drivers, such as Gross Profit of 59.3 M, Interest Expense of 17.7 M or Operating Expenses of 277 M, as well as many exotic indicators such as Interest Coverage of 7.48, Long Term Debt to Equity of 0.56 or PPandE Turnover of 1.67. Cytokinetics financial statements analysis is a perfect complement when working with Cytokinetics Valuation or Volatility modules. It can also supplement Cytokinetics' financial leverage analysis and stock options assessment as well as various Cytokinetics Technical models . Continue to the analysis of Cytokinetics Correlation against competitors.
Cytokinetics Quarterly Profit Margin  (0.223) 
Cytokinetics Profit Margin Breakdown
Showing smoothed Profit Margin of Cytokinetics with missing and latest data points interpolated. Measures the ratio between a company's Net Income Common Stock and Revenues.Cytokinetics' Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cytokinetics' overall financial position and show how it may be relating to other accounts over time.
View  Last Reported 0.00 %  10 Years Trend 

Profit Margin 
Share
Timeline 
Cytokinetics Profit Margin Regression Statistics
Arithmetic Mean  (4.58)  
Geometric Mean  2.56  
Coefficient Of Variation  (95.81)  
Mean Deviation  3.40  
Median  (3.30)  
Standard Deviation  4.39  
Sample Variance  19.25  
Range  12.83  
RValue  0.45  
Mean Square Error  16.71  
RSquared  0.20  
Significance  0.12  
Slope  0.51  
Total Sum of Squares  231.01 
Cytokinetics Profit Margin History
2012  5.51  
2013  1.1  
2014  0.31  
2015  1.31  
2016  0.16  
2017  9.56  
2018  3.37  
2019  4.53  
2020  2.28  
2021  3.06  
2022  3.3 
About Cytokinetics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Cytokinetics income statement, its balance sheet, and the statement of cash flows. Cytokinetics investors use historical funamental indicators, such as Cytokinetics's Profit Margin, to determine how well the company is positioned to perform in the future. Although Cytokinetics investors may use each financial statement separately, they are all related. The changes in Cytokinetics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Cytokinetics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Cytokinetics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Cytokinetics. Please read more on our technical analysis and fundamental analysis pages.
Cytokinetics, Incorporated, a latestage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company was incorporated in 1997 and is headquartered in South San Francisco, California. Cytokinetics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 253 people.
Last Reported  Projected for 2022  
Profit Margin  (3.06)  (3.30) 
Cytokinetics Investors Sentiment
The influence of Cytokinetics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decisionmaking process regarding taking a position in Cytokinetics. The overall investor sentiment generally increases the direction of a stock movement in a oneyear investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Cytokinetics' public news can be used to forecast risks associated with investment in Cytokinetics. The trend in average sentiment can be used to explain how an investor holding Cytokinetics can time the market purely based on public headlines and social activities around Cytokinetics. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Cytokinetics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Cytokinetics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Cytokinetics' news discussions. The higher the estimate score, the more favorable is the investor's outlook on Cytokinetics.
Cytokinetics Implied Volatility  100.81 
Cytokinetics' implied volatility exposes the market's sentiment of Cytokinetics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Cytokinetics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Cytokinetics stock will not fluctuate a lot when Cytokinetics' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cytokinetics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cytokinetics' short interest history, or implied volatility extrapolated from Cytokinetics options trading.
Pair Trading with Cytokinetics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cytokinetics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytokinetics will appreciate offsetting losses from the drop in the long position's value.Moving against Cytokinetics
0.55  ACHV  Achieve Life Sciences  Earnings Call Today  PairCorr  
0.51  ATHA  Athira Pharma  Earnings Call This Week  PairCorr 
The ability to find closely correlated positions to Cytokinetics could be a great tool in your taxloss harvesting strategies, allowing investors a quick way to find a similarenough asset to replace Cytokinetics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cytokinetics  that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cytokinetics to buy it.
The correlation of Cytokinetics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between 1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cytokinetics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cytokinetics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cytokinetics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better riskadjusted return on your portfolios.Continue to the analysis of Cytokinetics Correlation against competitors. Note that the Cytokinetics information on this page should be used as a complementary analysis to other Cytokinetics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for Cytokinetics Stock analysis
When running Cytokinetics price analysis, check to measure Cytokinetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytokinetics is operating at the current time. Most of Cytokinetics' value examination focuses on studying past and present price action to predict the probability of Cytokinetics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cytokinetics' price. Additionally, you may evaluate how the addition of Cytokinetics to your portfolios can decrease your overall portfolio volatility.
Transaction HistoryView history of all your transactions and understand their impact on performance  Go  
Alpha FinderUse alpha and beta coefficients to find investment opportunities after accounting for the risk  Go  
Balance Of PowerCheck stock momentum by analyzing Balance Of Power indicator and other technical ratios  Go  
Fund ScreenerFind activelytraded funds from around the world traded on over 30 global exchanges  Go  
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities  Go  
Price Exposure ProbabilityAnalyze equity upside and downside potential for a given time horizon across multiple markets  Go  
ETF DirectoryFind actively traded Exchange Traded Funds (ETF) from around the world  Go  
Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios  Go 
Is Cytokinetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytokinetics. If investors know Cytokinetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytokinetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization 4.6 B  Quarterly Revenue Growth YOY 30.29  Return On Assets 0.17  Return On Equity 3.38 
The market value of Cytokinetics is measured differently than its book value, which is the value of Cytokinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Cytokinetics' value that differs from its market value or its book value, called intrinsic value, which is Cytokinetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytokinetics' market value can be influenced by many factors that don't directly affect Cytokinetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytokinetics' value and its price as these two are different measures arrived at by different means. Investors typically determine Cytokinetics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytokinetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.